Injectable and self-implanting nanoscale neural interfaces
Cell-sized electronic or nanoparticle devices delivered by injection or the bloodstream that distribute through brain tissue and record or stimulate without open surgery.
State of the art
MIT "Circulatronics" monocyte-electronics hybrids injected intravenously self-implanted in an inflamed mouse brain region and stimulated with ~30 um precision (Nature Biotechnology 2025); magnetoelectric nanoparticles drove wireless deep brain stimulation in mice (2021).
- No scheme to individually power and address millions of untethered sub-cellular devices
- Egress bandwidth; nanoparticles can stimulate but cannot yet report spikes off-board
- Clearance, aggregation and long-term toxicity of persistent intraparenchymal devices
Who’s working on it
- Deblina SarkarResearcherMIT Media Lab
Circulatronics: immune-cell-electronics hybrids injected into the blood self-implanted in a target mouse brain region and were wirelessly powered (Nature Biotechnology 2025)
- Jacob RobinsonResearcherRice University
Magnetoelectric wireless power for distributed battery-free implant networks (Nature Biomedical Engineering 2025)
- Jia LiuResearcherHarvard SEAS
Co-inventor of syringe-injectable mesh electronics; 2025 Nature Electronics paper on wireless ultrathin brain interfaces
- SynchronStartup
Endovascular Stentrode in 10 patients by 2025; developing a transcatheter high-channel whole-brain interface
- Motif Neurotech ↗Startup
Commercialising Rice magnetoelectric power in a minimally invasive brain stimulator (FDA IDE 2026)
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Wireless power and uplink physics (magnetoelectric, ultrasonic, optical) demonstrated with thousands of individually addressable nodes in rodent brain | $$ $10M – $100M |
| engineering | Large-animal safety, distribution and longevity studies for injectable mesh and nanoparticle interfaces | $$ $10M – $100M |